These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30169652)

  • 1. Monitoring Fondaparinux in the Setting of Antithrombin Deficiency.
    Staley EM; Simmons SC; Feldman AZ; Williams LA; Pham HP
    Lab Med; 2019 Apr; 50(2):208-211. PubMed ID: 30169652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
    Hvas AM; Favaloro EJ; Hellfritzsch M
    Expert Rev Hematol; 2021 Apr; 14(4):335-346. PubMed ID: 33736552
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
    Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
    BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of fondaparinux in the setting of heparin-induced thrombocytopenia with thrombosis confirmed by serotonin-release assay and Factor V Leiden.
    Fraielli K; Patel D; Wang D; Sargent K; Gore J
    J Clin Pharm Ther; 2019 Oct; 44(5):809-812. PubMed ID: 31486123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
    Snodgrass MN; Shields J; Rai H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
    Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
    Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
    Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia treated with fondaparinux: single center experience.
    Dulicek P; Ivanova E; Kostal M; Fiedlerova Z; Sadilek P; Hirmerova J
    Int Angiol; 2020 Feb; 39(1):76-81. PubMed ID: 31782283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fondaparinux: a potential new therapy for HIT.
    Kuo KH; Kovacs MJ
    Hematology; 2005 Aug; 10(4):271-5. PubMed ID: 16085538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
    He Y; He H; Liu D; Long Y; Su L; Cheng W
    Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
    Blackmer AB; Oertel MD; Valgus JM
    Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.
    Dager WE; Andersen J; Nutescu E
    Pharmacotherapy; 2004 Jul; 24(7 Pt 2):88S-94S. PubMed ID: 15317404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
    Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
    Badger NO
    J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in heparin-induced thrombocytopenia: diagnosis and management.
    Spinler SA
    J Thromb Thrombolysis; 2006 Feb; 21(1):17-21. PubMed ID: 16475037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
    Al-Eidan FAS; Alrawkan S; Alshammary H; Crowther MA
    Ann Hematol; 2018 Nov; 97(11):2055-2059. PubMed ID: 30003318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis.
    Kušić J; Kulić A; Djurković V; Marković R; Milačić V; Surić-Lambić L; Peković G
    Srp Arh Celok Lek; 2016; 144(11-12):654-6. PubMed ID: 29659233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.